Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
19/08/2026 06:44
BRIEF-Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S. Aug 19 (Reuters) - Sedana Medical AB (publ) SEDANA.ST:
ANNOUNCES FDA ACCEPTANCE FOR REVIEW OF ITS NEW DRUG APPLICATION IN U.S.
Source text: ID:nMFNDlFmJ
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln